Edward G. Broenniman
Chairman of the Board
Edward G. Broenniman is an entrepreneur with substantial experience in the formation and development of high technology businesses. He became a director of Aethlon Medical, Inc. in March of 1999. Mr. Broenniman has 30 years of management and executive experience with high-tech, privately held growth firms where has he served as CEO, COO, or corporate advisor. He recently served on the Board of Directors of publicly traded QuesTech (acquired by CACI International), and currently is a director of four privately-held companies. His non-profit Boards are the Dingman Center for Entrepreneurship's Board of Advisors at the University of Maryland, the National Association of Corporate Directors, the National Capital Chapter, and the Board of the Association for Corporate Growth. Mr. Broenniman holds a BA from Yale University and an MBA from Stanford University.
Ms. Rossetti is a senior biopharmaceutical executive who brings more than 20 years of industry experience. She has served as a strategic consultant to Kala Pharmaceuticals, Inc. since October 2021, and prior to this was a consultant to Celgene Corporation. From June 2015 through July 2017, Ms. Rossetti held the position of Executive Vice President of Cell Machines, Inc., an early-stage biopharmaceutical company developing novel protein therapies where she assisted with the commercialization of technology for hemophilia and other diseases. Ms. Rossetti has held a number of positions within pharmaceutical commercial development, marketing, communications and finance, including Vice President of a Global Commercial Medicine Team at Pfizer Inc., where she led a global smoking cessation campaign. Ms. Rossetti currently holds positions as an adjunct Assistant Professor of Medical and Pharmaceutical Ethics at New York Medical College and an Adjunct Associate at Albert Einstein College of Medicine.
Chetan S. Shah, M.D.
Dr. Shah became a director of Aethlon Medical in June 2013. Dr. Shah is a board certified Otolaryngologist. He is an Advisory Board Member at The Bank of Princeton, and a founder, partner and Board member of the Surgery Center at Hamilton as well as Physician Management Systems and Princeton Eye & Ear.
Dr. Shah serves on the board of two other private companies. He holds teaching positions and serves on multiple hospital committees in the area and served as Vice-President on the Board of Medical Examiners for the State of New Jersey. Dr. Shah received his Bachelor’s degree and Medical Degree from Rutgers University and Robert Wood Johnson Medical School.
From 2021 to May 2023, Mr. Gikakis served as the Head of Commercial for WearOptimo Pty Ltd, a private Australian medical device and digital health company. Previously, from 2017 to 2019, Mr. Gikakis was Vice President of Strategy and Corporate Development at Oventus Medical Limited, a private medical device company, during which time he assisted with the commercial expansion of its sleep apnea device. From 2012 to 2021, Mr. Gikakis held various leadership and independent strategic advisor positions in the healthcare industry in sales, marketing, product development, and corporate development and transactions, including for companies working with blood filtration and purification.
Mr. Gikakis earned a BS in bioengineering from the University of Pennsylvania and holds an MBA from George Mason University, with earlier work in bench and clinical research, and clinical experience at the University of Pennsylvania.
James B. Frakes
Interim Chief Executive Officer and Chief Financial Officer
Mr. Frakes joined Aethlon Medical in January 2008. He has 27 years of CFO level financial responsibility for publicly traded companies, as well as, specific knowledge and experience in equity (IPO, follow-on public offerings and private placements) and debt transactions, acquisitions, public reporting and Sarbanes-Oxley section 404 internal control requirements.
Mr. Frakes received an MBA from the University of Southern California, and completed his BA with Honors at Stanford University.